Plain-English translation of NCT07699939 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Phase 2 β Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether adding (a medication that helps your immune system fight cancer) to standard chemotherapy works better than chemotherapy alone for people with locally advanced stomach cancer. You would receive chemotherapy plus either or a placebo (inactive treatment) before surgery, then have surgery to remove the cancer, and continue treatment afterward. The goal is to see if this combination approach helps more patients stay cancer-free longer.
Advanced stomach cancer is difficult to treat, and many patients experience cancer recurrence even after surgery. Researchers believe that this medication, which activates the body's immune system to recognize and attack cancer cells, may improve outcomes when combined with traditional chemotherapy.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You would first receive several weeks of chemotherapy combined with either or a placebo (you won't know which), along with regular clinic visits and blood tests. After this treatment phase, you would have surgery to remove the cancer. Then you would continue taking either or standard chemotherapy for several more months, with ongoing follow-up visits to monitor your health. The entire process, from start to finish, would likely span 6β12 months of active treatment, with longer-term follow-up visits afterward.
AI-generated summary from trial data Β· Aug 20, 2026 Β· Not medical advice
Japan